NASDAQ · BIIB
Biogen Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for BIIB has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $3.07 | $3.50 | $2.62 | 9 |
| Mar 2027 | $3.64 | $3.97 | $3.03 | 5 |
| Jun 2027 | $4.35 | $4.87 | $3.71 | 5 |
| Sep 2027 | $4.24 | $4.57 | $3.92 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · MarketBeat · The Motley Fool · Zacks- RTTNews · Oct 29, 5:00 AM EDTBioArctic Royalty Income Rises 74% As Leqembi Sales Reach JPY 32.2 Bln(RTTNews) – BioArctic AB (publ) (BIOA-B.ST) partner Eisai reported preliminary global revenue for Leqembi for the third quarter of 2026 in connection with Biogen Inc.'s (BIIB) third-quarter earnings release.
- MarketBeat · Oct 28, 6:04 PM EDTBiogen Q3 Earnings Call HighlightsMarketBeat Week in Review – 05/18 – 05/22Biogen (NASDAQ:BIIB) reported third-quarter 2026 revenue growth of 11% year over year, supported by its acquisition of Apellis and continued expansion of its growth-product portfolio. Management said the company remains on track to return
- The Motley Fool · Oct 28, 1:13 PM EDTBiogen (BIIB) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Oct 28, 12:11 PM EDTBIIB's Q3 Earnings Beat, New Drugs Aid Sales, '26 EPS View TightenedBiogen's Q3 earnings and revenues beat estimates as growth drugs drive sales, while the company tightens its 2026 adjusted EPS outlook amid rising costs.
- Zacks · Oct 28, 9:38 AM EDTBig Day for Econ Data, Hyperscaler EarningsWe have a solid slate of reports today, both of the earnings variety and regarding economic growth.
- Zacks · Oct 28, 9:33 AM EDTHow Are LLY's Neuroscience and Immunology Drugs Poised Ahead of Q3?Eli Lilly is expanding beyond GLP-1 drugs as neuroscience and immunology therapies fuel growth ahead of Q3 results, with Kisunla, Taltz and newer drugs in focus.
- Fintel · Oct 28, 9:02 AM EDTBiogen Inc. Reports Third Quarter 2026 Total Revenue of $2.8 billionBiogen Inc. reported its financial results for the third quarter ended September 30, 2026, with total revenue of $2.8 billion, representing an 11% increase year-over-year. The company's Growth Portfolio revenue reached $1.26 billion, an increase of 49% year-over-year, which inclu
- Zacks · Oct 28, 8:30 AM EDTBiogen (BIIB) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesWhile the top- and bottom-line numbers for Biogen (BIIB) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- RTTNews · Oct 28, 7:30 AM EDTBiogen Q3 26 Earnings Conference Call At 8:30 AM ET(RTTNews) – Biogen Inc. (BIIB) will host a conference call at 8:30 AM ET on October 28, 2026, to discuss Q3 26 earnings results.
- RTTNews · Oct 28, 7:09 AM EDTBiogen Slips To Loss In Q3; Raises Low-end Of FY26 Earnings View(RTTNews) – Biotech major Biogen Inc. (BIIB) reported Wednesday a loss in its third quarter, compared to prior year's profit, despite higher revenues. Further, the firm raised the lower end of fiscal 2026 earnings outlook, on a reported basis, and tightened underlying earnings vi
- Zacks · Oct 28, 6:50 AM EDTBiogen Inc. (BIIB) Tops Q3 Earnings and Revenue EstimatesBiogen (BIIB) delivered earnings and revenue surprises of +27.18% and +8.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 26, 8:38 AM EDTBiogen Q3 Preview: Will Growth Products Drive an Earnings Beat?Biogen heads into Q3 earnings with growth from new drugs and acquisitions potentially offsetting declining multiple sclerosis sales.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Biogen Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.